246 related articles for article (PubMed ID: 25131397)
1. Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: the importance of residue 262.
Pegg KM; Liu EM; George AC; LaCuran AE; Bethel CR; Bonomo RA; Oelschlaeger P
Protein Sci; 2014 Oct; 23(10):1451-60. PubMed ID: 25131397
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
3. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
4. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
[TBL] [Abstract][Full Text] [Related]
5. Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6.
Oelschlaeger P; Schmid RD; Pleiss J
Biochemistry; 2003 Aug; 42(30):8945-56. PubMed ID: 12885227
[TBL] [Abstract][Full Text] [Related]
6. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases.
Mojica MF; Mahler SG; Bethel CR; Taracila MA; Kosmopoulou M; Papp-Wallace KM; Llarrull LI; Wilson BM; Marshall SH; Wallace CJ; Villegas MV; Harris ME; Vila AJ; Spencer J; Bonomo RA
Biochemistry; 2015 May; 54(20):3183-96. PubMed ID: 25915520
[TBL] [Abstract][Full Text] [Related]
8. Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group.
de Souza J; Vieira AZ; Dos Santos HG; Faoro H
BMC Genomics; 2024 May; 25(1):508. PubMed ID: 38778284
[TBL] [Abstract][Full Text] [Related]
9. Structural Study of Metal Binding and Coordination in Ancient Metallo-β-Lactamase PNGM-1 Variants.
Park YS; Kim TY; Park H; Lee JH; Nguyen DQ; Hong MK; Lee SH; Kang LW
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664695
[TBL] [Abstract][Full Text] [Related]
10. Mutation S115T in IMP-Type Metallo-β-Lactamases Compensates for Decreased Expression Levels Caused by Mutation S119G.
Zhang CJ; Faheem M; Dang P; Morris MN; Kumar P; Oelschlaeger P
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31718049
[TBL] [Abstract][Full Text] [Related]
11. Difference in the Inhibitory Effect of Thiol Compounds and Demetallation Rates from the Zn(II) Active Site of Metallo-β-lactamases (IMP-1 and IMP-6) Associated with a Single Amino Acid Substitution.
Yamaguchi Y; Kato K; Ichimaru Y; Uenosono Y; Tawara S; Ito R; Matsuse N; Wachino JI; Toma-Fukai S; Jin W; Arakawa Y; Otsuka M; Fujita M; Fukuishi N; Sugiura K; Imai M; Kurosaki H
ACS Infect Dis; 2023 Jan; 9(1):65-78. PubMed ID: 36519431
[TBL] [Abstract][Full Text] [Related]
12. Role of Residues W228 and Y233 in the Structure and Activity of Metallo-β-Lactamase GIM-1.
Skagseth S; Carlsen TJ; Bjerga GE; Spencer J; Samuelsen Ø; Leiros HK
Antimicrob Agents Chemother; 2016 Feb; 60(2):990-1002. PubMed ID: 26643332
[TBL] [Abstract][Full Text] [Related]
13. Insight into stereochemistry of a new IMP allelic variant (IMP-55) metallo-β-lactamase identified in a clinical strain of Acinetobacter baumannii.
Shakibaie MR; Azizi O; Shahcheraghi F
Infect Genet Evol; 2017 Jul; 51():118-126. PubMed ID: 28336429
[TBL] [Abstract][Full Text] [Related]
14. B1-Metallo-β-Lactamases: Where Do We Stand?
Mojica MF; Bonomo RA; Fast W
Curr Drug Targets; 2016; 17(9):1029-50. PubMed ID: 26424398
[TBL] [Abstract][Full Text] [Related]
15. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
Salahuddin P; Kumar A; Khan AU
Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the substrate specificity of IMP-6 and IMP-1 metallo-β-lactamases.
Yamamoto K; Tanaka H; Kurisu G; Nakano R; Yano H; Sakai H
J Biochem; 2022 Dec; 173(1):21-30. PubMed ID: 36174533
[TBL] [Abstract][Full Text] [Related]
17. Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
Zhao WH; Hu ZQ; Shimamura T
J Med Microbiol; 2008 Aug; 57(Pt 8):974-979. PubMed ID: 18628498
[TBL] [Abstract][Full Text] [Related]
18. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
[TBL] [Abstract][Full Text] [Related]
19. RNA-hydrolyzing activity of metallo-β-lactamase IMP-1.
Kato Y; Takahashi M; Seki M; Nashimoto M; Shimizu-Ibuka A
PLoS One; 2020; 15(10):e0241557. PubMed ID: 33126240
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.
Brown NG; Horton LB; Huang W; Vongpunsawad S; Palzkill T
Antimicrob Agents Chemother; 2011 Dec; 55(12):5696-702. PubMed ID: 21896903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
